14-day Premium Trial Subscription Try For FreeTry Free

Breakout Stocks of Week 12

NASDAQ was down last week (week 11) by -0.696% ending at 15,973.17 points after falling -111.94 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are American Woodmark Corporation NASDAQ:AMWD. This stock has had a buy signal since Mar 15, 2024 when the price was $94.76 , but have so far fallen 0% to $94.76. Some other companies are on our watchlist to, among these are WW Grainger Inc NYSE:GWW Solar Capital Ltd. NASDAQ:SLRC BanColombia SA NYSE:CIB and Iteos Therapeutics Inc. NASDAQ:ITOS which all got a breakout pattern emerging.

Date Company Price Change
Mar 15, 2024 American Woodmark Corporation $94.76 $95.19 ( 18th Mar 2024 ) 0.454%
Mar 15, 2024 Ww Grainger Inc $994.37 $994.49 ( 18th Mar 2024 ) 0.0121%
Mar 15, 2024 Solar Capital Ltd. $15.13 $15.03 ( 18th Mar 2024 ) -0.661%
Mar 15, 2024 Bancolombia Sa $32.31 $33.16 ( 18th Mar 2024 ) 2.63%
Mar 15, 2024 Iteos Therapeutics Inc. $10.81 $10.26 ( 18th Mar 2024 ) -5.09%

American Woodmark Corporation

NASDAQ:AMWD Strong Buy Candidate Score: 5.83
Strong Buy Candidate Score: 5.83 Mar 15, 2024

American Woodmark CorporationThe American Woodmark Corporation stock price gained 1.65% on the last trading day (Friday, 15th Mar 2024), rising from $93.22 to $94.76. During the last trading day the stock fluctuated 2.46% from a day low at $92.57 to a day high of $94.85. The price has fallen in 7 of the last 10 days and is down by -7.34% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 243 thousand more shares were traded than the day before. In total, 350 thousand shares were bought and sold for approximately $33.20 million.

On Dec 07, 2023, it was reported that Deutsche Bank gave AMWD a "Hold" grade with a "upgrade" action.

American Woodmark Corporation holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About American Woodmark Corporation:
American Woodmark Corporation manufactures and distributes kitchen, bath, office, home organization, and hardware products for the remodelling and new home construction markets in the United States. The company offers made-to-order and cash and carry products. It also provides turnkey installation services to its direct builder customers through a network of eight service centers. The company sells its products under the American Woodmark, Timberlake, Shenandoah Cabinetry, Waypoint Living Spaces, Estate, Stor-It-All, and Professional Cabinet Solutions brands, as well as Hampton Bay, Glacier Bay, Style Selections, Allen + Roth, Home Decorators Collection, and Project Source. It markets its products directly to home centers and builders, as well as through independent dealers and distributors. The company was incorporated in 1980 and is based in Winchester, Virginia.

WW Grainger Inc

NYSE:GWW Buy Candidate Score: 4.26
Buy Candidate Score: 4.26 Mar 15, 2024

WW Grainger IncThe WW Grainger Inc stock price gained 0.270% on the last trading day (Friday, 15th Mar 2024), rising from $991.69 to $994.37. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.12% from a day low at $984.05 to a day high of $995.08. The price has risen in 6 of the last 10 days and is up by 1.37% over the past 2 weeks. Volume fell on the last day by -80 thousand shares and in total, 147 thousand shares were bought and sold for approximately $146.17 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On May 01, 2023, it was reported that Morgan Stanley gave GWW a "Underweight" grade with a "hold" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for WW Grainger Inc stock to perform well in the short-term.

About WW Grainger Inc:
W.W. Grainger, Inc. distributes maintenance, repair, and operating (MRO) products and services in the United States, Japan, Canada, the United Kingdom, and internationally. The company operates through two segments, High-Touch Solutions N.A. and Endless Assortment. It offers safety and security supplies, material handling and storage equipment, pumps and plumbing equipment, cleaning and maintenance supplies, and metalworking and hand tools. It also offers inventory management and technical support services. The company serves businesses, corporations, government entities, and other institutions through sales and service representatives, and electronic and ecommerce channels. W.W. Grainger, Inc. was founded in 1927 and is headquartered in Lake Forest, Illinois.

Solar Capital Ltd.

NASDAQ:SLRC Buy Candidate Score: 4.21
Buy Candidate Score: 4.21 Mar 15, 2024

Solar Capital Ltd.The Solar Capital Ltd. stock price gained 0.332% on the last trading day (Friday, 15th Mar 2024), rising from $15.08 to $15.13. During the last trading day the stock fluctuated 1.60% from a day low at $15.00 to a day high of $15.24. The price has risen in 6 of the last 10 days and is up by 0.67% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 72 thousand more shares were traded than the day before. In total, 350 thousand shares were bought and sold for approximately $5.30 million.

On Nov 09, 2022, it was reported that Compass Point gave SLRC a "Buy" grade with a "upgrade" action.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Solar Capital Ltd. stock to perform well in the short-term period.

About Solar Capital Ltd.:
SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $100 million. The fund invests in companies with revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.

BanColombia SA

NYSE:CIB Buy Candidate Score: 3.25
Buy Candidate Score: 3.25 Mar 15, 2024

BanColombia SAThe BanColombia SA stock price fell by -0.278% on the last day (Friday, 15th Mar 2024) from $32.40 to $32.31. During the last trading day the stock fluctuated 1.90% from a day low at $32.16 to a day high of $32.78. The price has fallen in 7 of the last 10 days and is down by -1.37% for this period. Volume has increased on the last day by 377 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 557 thousand shares were bought and sold for approximately $17.98 million.

On Dec 19, 2022, it was reported that Bradesco gave CIB a "Neutral" grade with a "initialise" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BanColombia SA stock to perform well in the short-term.

About BanColombia SA:
Bancolombia S.A. provides banking products and services in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala. The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other. It offers checking and savings accounts, fixed term deposits, and investment products; trade financing, loans funded by domestic development banks, working capital loans, credit cards, personal and vehicle loans, payroll loans, and overdrafts; financial support to real estate developers and mortgages for individuals and companies; factoring; and financial and operating leasing services. The company also provides hedging instruments, including futures, forwards, options, and swaps; and brokerage, investment advisory, and private banking services, including selling and distributing equities, futures, foreign currencies, fixed income securities, mutual funds, and structured products. In addition, it offers cash management services; foreign currency transaction services; life, auto, commercial, and homeowner's insurance products; and online and computer banking services. Further, the company provides project and acquisition finance, debt and equity capital markets, principal investments, M&A, hedging strategies, restructurings, and structured financing; money market accounts, mutual and pension funds, private equity funds, payment and corporate trust, and custody; internet-based trading platform; inter-bank lending and repurchase agreements; managing escrow accounts, and investment and real estate funds; and transportation, securities brokerage, maintenance and remodeling, and outsourcing services. As of December 31, 2021, it operated 1,015 branches; 28,676 banking correspondents; 529 PAMs; 210 kiosks in El Salvador and 187 in Colombia; and 6,094 ATMs. Bancolombia S.A. was incorporated in 1945 and is headquartered in Medellín, Colombia.

Iteos Therapeutics Inc.

NASDAQ:ITOS Buy Candidate Score: 3.22
Buy Candidate Score: 3.22 Mar 15, 2024

Iteos Therapeutics Inc.The Iteos Therapeutics Inc. stock price gained 0.746% on the last trading day (Friday, 15th Mar 2024), rising from $10.73 to $10.81. During the last trading day the stock fluctuated 3.48% from a day low at $10.63 to a day high of $11.00. The price has fallen in 7 of the last 10 days and is down by -4.08% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 124 thousand more shares were traded than the day before. In total, 240 thousand shares were bought and sold for approximately $2.60 million.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Iteos Therapeutics Inc. stock to perform well in the short-term period.

About Iteos Therapeutics Inc.:
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

.

StockInvest.usStock Podcast